Development of synthetic gene drives using small molecules
$357,272R01FY2022GMNIH
Brigham And Women'S Hospital, Boston MA
Investigators
Linked publications & trials
Paper 38484051Paper 38289340Paper 38110475Paper 38011259Paper 38000957Paper 37406109Paper 37398094Paper 37162925Paper 37131747Paper 36931733Paper 36931732Paper 36705519Paper 36396978Paper 34952739Paper 33376784Paper 33253976Paper 32610142
Abstract
PROJECT SUMMARY Gene drives enable a super-Mendelian inheritance where the chance of passing on the gene to the progeny is 100%, and this super-Mendelian inheritance has been demonstrated for several engineered genes in multiple organisms. Gene-drive mediated trait propagation in the entire ecosystem may find use in the elimination of diseases (e.g., malaria, dengue fever) or invasive species, and reversing the pesticide resistance in plants. We propose to use tools and principles of chemistry to develop controllers that will allow us to understand the strength and limitations of the gene drive technologies.
View original record on NIH RePORTER →